BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16388603)

  • 21. Structure-based mechanism of ADP-ribosylation by sirtuins.
    Hawse WF; Wolberger C
    J Biol Chem; 2009 Nov; 284(48):33654-61. PubMed ID: 19801667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into the sirtuin mechanism from ternary complexes containing NAD+ and acetylated peptide.
    Hoff KG; Avalos JL; Sens K; Wolberger C
    Structure; 2006 Aug; 14(8):1231-40. PubMed ID: 16905097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of NAD(+) in the deacetylase activity of the SIR2-like proteins.
    Landry J; Slama JT; Sternglanz R
    Biochem Biophys Res Commun; 2000 Nov; 278(3):685-90. PubMed ID: 11095969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Function and metabolism of sirtuin metabolite O-acetyl-ADP-ribose.
    Tong L; Denu JM
    Biochim Biophys Acta; 2010 Aug; 1804(8):1617-25. PubMed ID: 20176146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for the mechanism and regulation of Sir2 enzymes.
    Avalos JL; Boeke JD; Wolberger C
    Mol Cell; 2004 Mar; 13(5):639-48. PubMed ID: 15023335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
    Avalos JL; Bever KM; Wolberger C
    Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural insights into intermediate steps in the Sir2 deacetylation reaction.
    Hawse WF; Hoff KG; Fatkins DG; Daines A; Zubkova OV; Schramm VL; Zheng W; Wolberger C
    Structure; 2008 Sep; 16(9):1368-77. PubMed ID: 18786399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis for nicotinamide inhibition and base exchange in Sir2 enzymes.
    Sanders BD; Zhao K; Slama JT; Marmorstein R
    Mol Cell; 2007 Feb; 25(3):463-72. PubMed ID: 17289592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small molecule regulation of Sir2 protein deacetylases.
    Grubisha O; Smith BC; Denu JM
    FEBS J; 2005 Sep; 272(18):4607-16. PubMed ID: 16156783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked?
    Zhang J
    Bioessays; 2003 Aug; 25(8):808-14. PubMed ID: 12879452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzymatic assays for NAD-dependent deacetylase activities.
    Landry J; Sternglanz R
    Methods; 2003 Sep; 31(1):33-9. PubMed ID: 12893171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of endogenous sirtuin metabolite O-acetyl-ADP-ribose.
    Lee S; Tong L; Denu JM
    Anal Biochem; 2008 Dec; 383(2):174-9. PubMed ID: 18812159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The reaction mechanism for CD38. A single intermediate is responsible for cyclization, hydrolysis, and base-exchange chemistries.
    Sauve AA; Munshi C; Lee HC; Schramm VL
    Biochemistry; 1998 Sep; 37(38):13239-49. PubMed ID: 9748331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linking chromatin function with metabolic networks: Sir2 family of NAD(+)-dependent deacetylases.
    Denu JM
    Trends Biochem Sci; 2003 Jan; 28(1):41-8. PubMed ID: 12517451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of the yeast Hst2 protein deacetylase in ternary complex with 2'-O-acetyl ADP ribose and histone peptide.
    Zhao K; Chai X; Marmorstein R
    Structure; 2003 Nov; 11(11):1403-11. PubMed ID: 14604530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of O-acetyl-ADP-ribose as a target for Nudix ADP-ribose hydrolases.
    Rafty LA; Schmidt MT; Perraud AL; Scharenberg AM; Denu JM
    J Biol Chem; 2002 Dec; 277(49):47114-22. PubMed ID: 12370179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism-based modulator discovery for sirtuin-catalyzed deacetylation reaction.
    Zheng W
    Mini Rev Med Chem; 2013 Jan; 13(1):132-54. PubMed ID: 22876953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of a Sir2 enzyme bound to an acetylated p53 peptide.
    Avalos JL; Celic I; Muhammad S; Cosgrove MS; Boeke JD; Wolberger C
    Mol Cell; 2002 Sep; 10(3):523-35. PubMed ID: 12408821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmodium falciparum Sir2 is an NAD+-dependent deacetylase and an acetyllysine-dependent and acetyllysine-independent NAD+ glycohydrolase.
    French JB; Cen Y; Sauve AA
    Biochemistry; 2008 Sep; 47(38):10227-39. PubMed ID: 18729382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sirtuin mechanism and inhibition: explored with N(ε)-acetyl-lysine analogs.
    Hirsch BM; Zheng W
    Mol Biosyst; 2011 Jan; 7(1):16-28. PubMed ID: 20842312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.